Radiation Therapy for Early Stage Lung Cancer

Stereotactic body radiation therapy for inoperable early stage lung cancer.

CONTEXT Patients with early stage but medically inoperable lung cancer have a poor rate of primary tumor control (30%-40%) and a high rate of mortality (3-year survival, 20%-35%) with current management. OBJECTIVE To evaluate the toxicity and efficacy of stereotactic body radiation therapy in a high-risk population of patients with early stage but medically inoperable lung cancer. DESIGN, S...

Stereotactic radiation therapy for inoperable, early-stage non-small-cell lung cancer.

Robotic stereotactic body radiation therapy for elderly medically inoperable early-stage non-small cell lung cancer.

INTRODUCTION Stereotactic body radiation therapy (SBRT) is being increasingly applied in the treatment of non-small cell lung cancer (NSCLC) because of its high local efficacy. This study aims to examine survival outcomes in elderly patients with inoperable stage I NSCLC treated with SBRT. METHODS A total of 31 patients with single lesions treated with fractionated SBRT from 2008 to 2011 were...

Stereotactic Body Therapy Radiation for the Treatment of Early Stage Non Small Cell Lung Cancer AUTHOR:

Stereotactic Body Radiation Therapy for the Treatment of Early Stage Non Small Cell Lung Cancer

The California Technology Assessment Forum was requested to review the scientific evidence for the use of Stereotactic Body Radiation Therapy (SBRT) for the treatment of early stage non small cell lung cancer (NSCLC) in medically inoperable patients. Given that the major treatment goal for non small cell lung cancer is to obtain local control, is SBRT a viable therapeutic option for patients wh...